Company No:
Contents
DIRECTOR | Mr K Copeland |
REGISTERED OFFICE | 6 Bevis Marks |
London | |
EC3A 7BA | |
United Kingdom |
COMPANY NUMBER | 03336645 (England and Wales) |
Note | 2023 | 2022 | ||
£ | £ | |||
Fixed assets | ||||
Investments | 3 |
|
|
|
112,344 | 112,344 | |||
Current assets | ||||
Debtors | 4 |
|
|
|
Cash at bank and in hand |
|
|
||
24,837 | 24,915 | |||
Creditors: amounts falling due within one year | 5 | (
|
(
|
|
Net current liabilities | (147,246) | (143,477) | ||
Total assets less current liabilities | (34,902) | (31,133) | ||
Net liabilities | (
|
(
|
||
Capital and reserves | ||||
Called-up share capital |
|
|
||
Profit and loss account | (
|
(
|
||
Total shareholder's deficit | (
|
(
|
Director's responsibilities:
These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of LBC INTL LTD. (registered number:
Mr K Copeland
Director |
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act2006.
LBC Intl Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales.
The address of the Company's registered office is:
22 Chancery Lane
London
WC2A 1LS
The financial statements have been prepared under the historical cost convention.
The financial statements have been prepared on a going concern basis. Meaden & Moore International Inc., the immediate parent company, has confirmed it will continue to support the company for a period of not less than one year from the date of approval of the financial statements.
Income from the LLP of which the company is a member is recognised in the period to which the LLP allocates the income.
Investments in associated undertakings are measured at cost less impairment.
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.
2023 | 2022 | ||
Number | Number | ||
Average number of persons employed by the company |
|
|
Investments in associates | Total | ||
£ | £ | ||
Cost or valuation before impairment | |||
At 01 January 2023 |
|
|
|
At 31 December 2023 |
|
|
|
Carrying value at 31 December 2023 |
|
|
|
Carrying value at 31 December 2022 |
|
|
The financial period end of Meaden & Moore International LLP is 31 December. The loss for the financial period of Meaden & Moore International LLP was £156,270 (2022 - loss of £330,127) and the aggregate amount of capital and reserves at the end of the period was £(822,774) (2022 - £(641,006)).
2023 | 2022 | ||
£ | £ | ||
Amounts owed by group undertakings |
|
|
2023 | 2022 | ||
£ | £ | ||
Amounts owed to group undertakings |
|
|
|
Other taxation and social security |
|
|
|
Other creditors |
|
|
|
|
|